v3.25.2
Statements of Cash Flows - USD ($)
10 Months Ended 12 Months Ended
May 31, 2024
May 31, 2025
Cash Flows From Operating Activities:    
Net loss $ (3,933) $ (23,635)
Depreciation 138 1,458
Changes in operating assets and liabilities:    
Accounts receivable (5,000) 5,000
Prepayment (1,199)
Accrued liabilities 8,500
Amounts due to a director [1] 2,929 8,415
Net cash (used in) / provided by operating activities 2,634 (9,961)
Cash Flows From Investing Activity:    
Purchase of plant and equipment (1,659) (3,900)
Net cash used in investing activity (1,659) (3,900)
Cash Flows From Financing Activity:    
Proceeds from issuance of shares 2,000 48,000
Net cash provided by financing activity 2,000 48,000
Net change in cash and cash equivalents 2,975 34,139
Cash and cash equivalents, beginning of period 2,975
Cash and cash equivalents, end of period 2,975 37,114
Supplemental cash flows information    
Income taxes paid
Interest paid
[1] As of November 30, 2024, the sole director of the Company advanced $11,344 to the Company, which is unsecured and non-interest bearing with repayable on demand. Our sole director, Zonghan Wu waived the repayment of the $11,344 loan. As such, there are currently no interested/related